Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill
- 1 January 1993
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 100 (1) , 79-84
- https://doi.org/10.1111/j.1471-0528.1993.tb12956.x
Abstract
Objective To study the fibrinolytic pathways and their relationship with the contact system in women using combined oral contraceptives (COCs).Design Serial plasma samples were collected from 18 women before treatment with COCs containing 30 μg oestrogen during treatment cycles 3 and 6, and 2 weeks after stopping treatment. Fibrinolysis was measured before and after dextran sulphate mediated contact activation using fibrin plates.Results Fibrinolysis increased significantly during cycles 3 and 6 (from 77% to 100% and 113%, respectively, PPPPPPConclusions The increase in fibrinolysis may be due to increased levels of Factor XII and prekallikrein without a corresponding increase in their natural inhibitors (C1‐esterase inhibitor and alpha‐2‐macroglobulin). A parallel increase in the intrinsic pathway of coagulation may be limited by elevated alpha‐1‐antitrypsin at the level of activated Factor XI. The increase in fibrinolysis caused by oral contraceptives may balance any potential thrombotic risk due to increased fibrinogen or vitamin K dependent coagulation factors.Keywords
This publication has 27 references indexed in Scilit:
- Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.BMJ, 1991
- Effects of long-term gestodene-containing oral contraceptive administration on hemostasisAmerican Journal of Obstetrics and Gynecology, 1990
- A comparison of the effects of two triphasic oral contraceptives on haemostasisBritish Journal of Haematology, 1988
- Analogous features of cold-promoted activation and contact system activation in human plasmas: the role of cryptic soluble surfaces in asthma, oral contraception and pregnancyThrombosis Research, 1987
- A microtitre chromogenic substrate assay for factor XIIThrombosis Research, 1987
- Oral contraceptives reduce total protein S, but not free protein S.Thrombosis Research, 1987
- Inactivation of Factor XIa by Plasma Protease InhibitorsJournal of Clinical Investigation, 1982
- Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “like” activity in human plasmaThrombosis Research, 1982
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980